Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer discovery, 2017 - AACR
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …
被引用次数：845 相关文章

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

V Anagnostou, KN Smith, PM Forde… - Cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

V Anagnostou, KN Smith, PM Forde… - Cancer …, 2017 - pure.johnshopkins.edu
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immune checkpoint inhibitors have shown
significant therapeutic responses against tumors containing increased mutation-associated …

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer …, 2017 - escholarship.org
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …
[HTML] nih.gov

[HTML][HTML] Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer …, 2017 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer …, 2016 - europepmc.org
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …